Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04775550
Title DARA RVD For High Risk SMM (PRISM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Omar Nadeem
Indications

multiple myeloma

Therapies

Bortezomib + Daratumumab + Dexamethasone + Lenalidomide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.